(Q36801179)

16 August 2017

1 reference

title

MR contrast agents: physical and pharmacologic basics (English)

1 reference

16 August 2017

1 reference

Shao-Pow Lin

1

1 reference

PubMed ID

17457803

16 August 2017

Jeffrey J Brown

series ordinal

2

1 reference

16 August 2017

1 May 2007

1 reference

Journal of Magnetic Resonance Imaging

16 August 2017

1 reference

16 August 2017

25

1 reference

16 August 2017

5

1 reference

16 August 2017

884-899

1 reference

Safety considerations in MR imaging

16 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Extravasation of radiographic contrast material: recognition, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Excretion of gadopentetate dimeglumine in human breast milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Cranial MR imaging with Gd-DTPA in neonates and young infants: preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20955

21 January 2018

Identifiers

DOI

10.1002/JMRI.20955

1 reference

16 August 2017

1 reference

PubMed ID

17457803